Oncology studies and studies evaluating the effects of recombinant human IL-6 support a causal link between IL-6 production and the development of anemia in patients with chronic disease, contributing to inflammatory conditions in chronic-diseased tissues [214]. This evidence concerns the gene IL6 and anemia (phenotype).